Related Experiment Video

Updated: Aug 15, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Current status of gene therapy for lung cancer and head and neck cancer

Chulso Moon1, Yun Oh, Jack A Roth

  • 1Department of Otolaryngology and Oncology, The Johns Hopkins School of Medicine and The Sidney Kimmel Cancer Center, Baltimore, Maryland 21205, USA. cmoon5@jhmi.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 14, 2003
PubMed

Insights

Cancer gene therapy, particularly using wild-type p53, shows promise in lung and head and neck cancers. Further research into delivery systems and combination therapies is needed for improved clinical success.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Targeting cancer's genetic basis offers effective therapeutics with reduced toxicity.
  • Gene replacement strategies for tumor suppressor pathways are explored in lung and head and neck cancers (HNC).

Purpose of the Study:

  • To review general cancer gene therapy principles.
  • To examine recent advancements in gene therapy for HNC and non-small cell lung cancer.

Main Methods:

  • Focus on wild-type p53 tumor suppressor gene delivery via adenoviral vectors.
  • Review of clinical trial data for gene transduction, expression, apoptosis, and clinical responses.

Main Results:

  • Clinical trials demonstrate successful gene transduction and expression in non-small cell lung cancer and HNC.
  • Evidence of apoptosis mediation and clinical responses, including pathological complete responses, has been observed.

Conclusions:

  • Current gene therapy approaches, like p53 replacement, show efficacy but require further optimization.
  • Future directions include enhanced delivery systems, bystander effects, immunogene/antiangiogenesis therapies, and combination treatments.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...